Supplementary Material - Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial

Name: Supplementary Material - Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial
Creator: Lisa Beck
Published: 2022-11-29T16:52:41.142Z
Keywords: Dermatology, Microbiome, Clinical Trial, Atopic Dermatitis

Beck, Lisa; Bieber, Thomas; Weidinger, Stephan; Tauber, Marie; Saeki, Hidehisa; Irvine, Alan; Eichenfield, Lawrence; Werfel , Thomas; Arlert, Petra; J, Li; Røpke, Mads; Paller, Amy

doi:10.17632/vnfbmxpx22.1

Supplementary Material - Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial

Published: 29 November 2022| Version 1 | DOI: 10.17632/vnfbmxpx22.1

Contributors:

Lisa Beck, Thomas Bieber, Stephan Weidinger, Marie Tauber, Hidehisa Saeki, Alan Irvine, Lawrence Eichenfield, Thomas Werfel , Petra Arlert, Li J, Mads Røpke, Amy Paller

Description

Supplementary Information to accompany and support the manuscript: Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: analysis of microbial diversity in ECZTRA 1, a randomized controlled trial.

Files

Funding

LEO Pharma

Supplementary Material - Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial

Description

Files

Categories

Funding

Licence